 |
인쇄하기
취소
|
Drug review provisions massively to reshuffle.
Lawyer Park Jeong-il, a legal adviser for the KFDA, suggested his plans to reshuffle the relevant provisions of drug review in the meeting on the subject of the drug safety scheduled on Sept. 5.
The current provision describes that the drugs fallen under Article 26 paragraph 6 of the Working Rules of the Pharmaceutical Affairs Act should be reviewed by the KFDA in 3 months after 4 to 6 years...
The current provision describes that the drugs fallen under Article 26 paragraph 6 of the Working Rules of the Pharmaceutical Affairs Act should be reviewed by the KFDA in 3 months after 4 to 6 years...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.